CC5-MRSA-IV (Maltese Clone); agr group II |
16 (55.2%) |
Oxacillin, Fusidic Acid, Streptogramins |
mecA, blaZ, blaI, blaR, fosB, Q6GD50
|
Neg |
Pos |
A, C, L, egc-cluster |
|
1 (3.4%) |
Fusidic Acid, Streptogramins |
mecA, fosB, Q6GD50
|
Neg |
Neg |
A, egc-cluster |
|
2 (6.8%) |
Fusidic Acid, Streptogramins |
mecA, blaZ, blaI, blaR, fosB, Q6GD50
|
Neg |
Pos |
A, C, L, egc-cluster |
|
1 (3.4%) |
N/A |
mecA, blaZ, blaI, blaR, fosB, Q6GD50
|
Neg |
Pos |
A, C, L, egc-cluster |
|
1 (3.4%) |
N/A |
mecA, blaZ, blaI, blaR, fosB, Q6GD50
|
Neg |
Neg |
A, ecg-cluster |
|
CC22-MRSA-IV (Barnim/UK-EMRSA-15); agr group I |
1 (3.4%) |
Oxacillin, Levofloxacin, Moxifloxacin, Fusidic Acid, Streptogramins, Vancomycin-intermediate |
mecA, blaZ, blaI, blaR, Q6GD50, ermC
|
Neg |
Neg |
C, L, egc-cluster |
|
1 (3.4%) |
Oxacillin, Levofloxacin, Moxifloxacin, Streptogramins |
mecA, blaZ, blaI, blaR, |
Neg |
Neg |
C, L, egc-cluster |
|
1 (3.4%) |
Oxacillin, Levofloxacin, Moxifloxacin, Streptogramins |
mecA, blaZ, blaI, blaR, |
Neg |
Neg |
B, C, L, egc-cluster |
|
2 (6.8%) |
Oxacillin, Levofloxacin, Moxifloxacin-intermediate, Streptogramins |
mecA, blaZ, blaI, blaR, |
Neg |
Neg |
B, C, L, egc-cluster |
|
ST6-MRSA-IV (WA-MRSA-51); agr group I |
1 (3.4%) |
Oxacillin, Erythromycin, Clindamycin, MLSB inducible |
mecA, blaZ, blaI, blaR, ermC; sat, fosB
|
Neg |
Neg |
A |
|
CC80-MRSA-IV; agr group III |
1 (3.4%) |
Oxacillin, Tetracycline, Fusidic Acid, Streptogramins |
mecA, blaZ, blaI, blaR, aphA, sat, far1, tetK |
Neg |
Neg |
Neg |
Other toxins: exfoliative toxin D, EDIN-B |
CC50 (New Strain); agr group IV |
1 (3.4%) |
Oxacillin, Fusidic Acid, Streptogramins |
mecA, blaZ, blaI, blaR, Q6GD50
|
Neg |
Neg |
ecg-cluster |
|